<DOC>
	<DOCNO>NCT00243490</DOCNO>
	<brief_summary>Primary Objective : - The primary objective evaluate efficacy photodynamic therapy treatment malignant intracranial tumor . Secondary Objective : - The secondary objective evaluate safety photodynamic therapy treatment malignant intracranial tumor .</brief_summary>
	<brief_title>Photodynamic Therapy Treatment Malignant Intracranial Tumors</brief_title>
	<detailed_description>After pass Photosan® allergic test , patient inject intravenously Photosan® ( 2mg/kg ) 15~30 minute , 48 hour prior standard craniotomy . Precautions take expose patient operating room direct room operate light shield skin flap operation . Steroids withdraw 2-3 day prior sensitization . After maximal resection , surface tumor bed calculate generated cavity keep balloon contain intralipid ( 0.1 % ) saline and/or artificial spinal fluid . A fiber spherical diffuser center cavity surface irradiate red ( 625~635nm ) Halogen light . The dose light irradiation depend individual condition patient , usually energy density 100 J/cm2 power density 500 mW/cm2 600 mW/cm2 .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Astrocytoma</mesh_term>
	<mesh_term>Ependymoma</mesh_term>
	<mesh_term>Oligodendroglioma</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<criteria>1 . Hospital inpatient age 20 year age 75 year , male female . 2 . Patients diagnose primary recurrent malignant intracranial tumor ( Grade III Grade IV glioma define World Health Organization [ WHO ] classification ) , include anaplastic astrocytomas , anaplastic oligodendrogliomas , anaplastic ependymal tumor glioblastoma multiforme . 3 . Suitable gross total resection basis image study doctor 's point view 4 . Karnofsky Performance Scale ( KPS ) ≥ 60 newly diagnose tumor 5 . KPS ≥ 70 recurrent tumor 6 . Life expectancy least 3 month 7 . Not pregnant lactating . 8 . Patients willing participate trial sign write informed consent 1 . Subject know , suspected history intolerance allergy porphyrin . 2 . Renal dysfunction ( serum creatinine &gt; 1.5 mg/dL ) 3 . PT/PTT great 1.5 time upper limit normal ( ULN ) 4 . Bilirubin liver function test ( LFTs ) great 2 time ULN 5 . Alkaline phosphatase great 3 time ULN 6. γGT great 3 time ULN 7 . Severe cardiac disease , e.g . angina pectoris , myocardial infarction , cardiac arrhythmia , congestive heart failure ( New York Heart Association Functional Classification III IV ) . 8 . Febrile illness total leukocyte count &lt; 3,000/µL and/or platelet count &lt; 80,000/µL . 9 . Implantable electronic medical device pacemaker , lifesustaining electronic medical device artificial heartlung machine , contact type electronic medical device electrocardiograph , others artificial middle ear , artificial inner ear , metal artificial cardiac valve gold haemostatic clip . 10 . Organ transplant . 11 . History evidence severe illness condition would make patient , opinion investigator unsuitable study . 12 . Significant alcohol , drug medication abuse judged investigator . 13 . History treatment investigational drug within four week start study . 14 . Tumors locate within cerebellum brainstem</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Photodynamic therapy</keyword>
	<keyword>Malignant glioma</keyword>
	<keyword>Photosan</keyword>
</DOC>